Introduction
Spontaneous miscarriage and pre-eclampsia are major disorders appearing during pregnancy. Spontaneous miscarriage affects 50-60% of pregnant women and pre-eclampsia about 6-8%. It is also estimated that 1 to 3% of women may develop recurrent pregnancy loss (RPL). Its known etiologic factors are chromosomal anomalies, hormonal problems, uterine abnormalities, infections and immune disorders. Just impaired immune mechanisms account for the etiology of less than half of all cases of RPL [1] . Pre-eclampsia, another serious pregnancy complication, is a multisystemic disorder that is manifested by hypertension, proteinuria and abnormal blood clotting. Advanced clinical symptoms include seizures, renal failure, IUGR (intrauterine growth restriction) and/or HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome. Finally, generalized damage of the maternal endothelium, kidneys and liver can develop, leading to increased mortality risk for the mother as well as the foetus. The clinical symptoms of pre-eclampsia can be observed in the second or third trimester in pregnancy, and are the most common in primiparas [2] . Despite many research studies, the pathology of pre-eclampsia is not fully understood. One cause may originate in an insufficiently developed placenta, referred to as poor placentation. It is characterised by impaired remodelling of spiral arteries of the uterus (endothelial dysfunction) caused by an imbalance of circulating angiogenic factors. High circulating levels of soluble Fms like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng), a circulating receptor or TGF-b (both anti-angiogenic factors), and low levels of circulating vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) (both pro-angiogenic factors) have been described [3] . VEGF is the main factor that supports angiogenesis. sFlt1 (a splice variant of VEGF receptor FLT-1) acts as a VEGF and PlGF antagonist by binding these molecules in the circulatory system and in target tissues such as those of the kidney [4] . The higher concentrations of antiangiogenic factors trigger vascular endothelial cell injury in the liver, kidney, and brain, as well as the placenta itself.
Other key mechanisms leading to pre-eclampsia besides poor placentation are inflammation and impaired immune response at the placental-maternal interface, triggered by oxidative stress [5] . It has been observed that during pre-eclampsia, an abnormal maternal immune response to pregnancy develops involving proinflammatory cytokines such as tumor necrosis factor (TNF), interferon gamma (IFN-g) and interleukin 6 (IL-6) [6] . Thus, it seems that immune mechanisms are involved in pregnancy disorders such spontaneous miscarriage or pre-eclampsia. HLA-G (human leukocyte antigen G) is one of the molecules that induce immune tolerance and thus is important in the acceptance of the foetus by the maternal immune system [7] , suggesting it may be involved in the studied disorders.
An immunological view on pregnancy disorders
It is known that the physiological function of the immune system is important in successful foetal development (Figure 1 ). At the beginning of pregnancy, the immune response that supports embryonic implantation, angiogenesis and trophoblast development is induced. The T helper 1 (Th1) immune response characterised by pro-inflammatory cytokines TNF-a and IFN-g is later changed to T helper 2 (Th2) with IL-4 and IL-10 production and subsequently immune tolerance to the allogenic foetus is established [8] . The physiological pregnancy is characterised by Th2-type immunity, increased regulatory T cells activity and decreased natural killer (NK) cells activity [9] . The immune tolerance is also supported by selective expression of HLA-C, -E, -F and -G molecules on cytotrophoblast cells and production of complement regulatory proteins (DAF -decay-accelerating factor, MCP -membrane cofactor protein) and immunosuppressive enzymes such indoleamine 2, 3-dioxygenase (IDO) [10] . It has been established that a serious uterine infection can cause miscarriage, but a mild and trivial infection and inflammation may still be an important risk factor in this regard and may also affect embryo implantation. A possible explanation is the ability of pro-inflammatory cytokines such as tumour necrosis factor (TNF), IL-1b and IL-6 to promote the detection of incompatible human leukocyte antigen (HLA) proteins -which are expressed on the cells of the developing embryo -by activated macrophages, T-lymphocytes and NK cells [11] . Moreover, an infection and any consequent inflammation may create conditions for an increased stickiness of the platelets and white cells to the endothelial cells, generally leading to a procoagulant tendency and a reduction in blood flow within the endometrial vasculature [12] .
It has been reported that 30% of women with RPL show foetal rejection caused by autoantibodies, mostly anti-phospholipid (APA), antinuclear (ANA) and antithyroid antibodies (ATA). These cause trophoblast damage by complement activation as well as inducing thrombosis [13] .
In the first trimester of pregnancy, 30-40% of the decidua consists of maternal immune cells. Most of these are decidual natural killer cells (dNKs) (70%); the remainder are macrophages (<30%), T lymphocytes (<20%) and dendritic cells (DC; <2%) [14] . [15] . Moreover, the dNK cells express significantly higher levels of additional genes coding for integrins, lectin-like receptors, KIRs (killer-immunoglobulin like receptors) and cytokines. Production of cytokines by dNKs must be regulated very strictly. The mRNA for granulocyte colony-stimulating factor (G-CSF), macrophage colonystimulating factor (M-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), TNF-a, IFN-g, TGF-b and leukemia inhibitory factor (LIF) have been found in decidual CD56 + cells. By contrast, peripheral blood NK cells express only TNF-a and TGF-b1 [16] . It has been observed that dNK cells play an important role in the regulation of the maternal immune response to the foetal allograft and are involved in the control of trophoblast growth and its invasion during human pregnancy [17] . For instance, a secretion of growth factors such as vascular endothelial growth factor (VEGF) and cytokines such interferon gamma (IFN-γ) by dNKs is important for invasion of the trophoblast into the endometrium and supports the vascular remodelling of the uterus [18] . In relation to abortion, it has been shown that dNK cells from women with RPL express a limited number of KIRs and lack the specificity for foetal HLA-C molecules on trophoblasts, which are involved in inhibition of NK cell function. Furthermore, the dNK cells exhibit up-regulated amounts of activatory KIR receptors [19] . In pre-eclamptic women, the level of NK cells -both peripheral and decidual -is also increased [20] . Pre-eclampsia has also been observed more frequently in women who are homozygous for the group A KIR haplotypes (a combination of alleles of different loci that are inherited together) compared to those homozygous for the group B, as the B group haplotypes comprise more genes involved in the inhibition of NK cell activities [21] .
In order to protect the foetal allograft during pregnancy, the activities of the adaptive immune system should be suppressed. The type of antigen presenting cell (APC)and cytokines, together with the dose of antigen, are important factors which direct the differentiation of the naive Th0 lymphocytes. The dose of antigen during pregnancy regulates the expression of non-maternal (i.e. paternally) inherited proteins on the trophoblast at the maternal-foetal interface. In relation to this, CD4 + T cells play an important role in physiological pregnancy. They account for about 10% of the decidual leukocyte population and can differentiate into Th1, Th2, Th17 and Treg cells. Th1 cells produce mainly IL-2, IL-6, IL-12, IFN-g and TNF-a and induce cell-mediated responses. The Th2 cells secreting IL-4, IL-5, IL-10, IL-13 and granulocyte-macrophage colony-stimulating factor (GM-CSF) are engaged in regulation of the humoral response. During physiological pregnancy, immune responses mediated by Th1 lymphocytes are inhibited and the function of Treg lymphocytes is elevated; thus, Th1 cytokines such TNF-a and IFN-g play an important role in spontaneous abortion. These cytokines induce Fasmediated apoptosis of trophoblasts in vitro, whereas IL-6 and IL-10 induce resistance [21] . In women with RPL, increased Th1/Th2 ratios and Th1 directed polarization in peripheral blood have been observed [22, 23] . In preeclamptic women, the serum levels of TNF-a, IL-6 and IL-8 are increased, while the IL-10 level is decreased when compared to healthy controls [24] . Therefore, the clinical features of pre-eclampsia are characterized by an abnormal cytokine-mediated maternal inflammatory response.
Regulatory T cells (Treg) are another group of cells that are active in immunosuppression during pregnancy. The CD4 + CD25
+ Treg cells develop from naive T cells in the thymus by activation of FoxP3 (forkhead box P3) expression. It has been reported that decidual and/ or peripheral blood Treg cells increase during early pregnancy and then decrease at the end of pregnancy [25] . Exact factors that attract Treg cells into the pregnant uterus are not elucidated, but Schumacher et al. [26] have confirmed an important role for human chorionic gonadotropin (hCG) produced by the blastocyst immediately after fertilization.
Treg cells induce an anti-inflammatory response by secretion of transforming growth factor beta (TGF-b), IL-10 and IL-35. Other immunosuppressive activities include an apoptosis induction, a modulation of dendritic cells (DC) function [27] and secretion of enzyme IDO, which decreases the level of tryptophan needed for the proliferation of T cells [28] . Expression of HLA-G on DCs can also be induced by IDO, suggesting that these two molecules probably interact in establishing foetomaternal tolerance [29] . In women with RPL or preeclampsia, decreased numbers of Treg cells in both the decidua and in the peripheral blood, along with impaired Treg function, was observed [30, 31] . Previous findings showed that decidual T cells were more responsive to IL-2 and IFN-γ in the miscarriage group; this may suggest that increased Th1 type immunity arises from impaired Treg cell function [30] .
Recently T helper 17 (Th17) cells were added to those involved in immune regulation. Th17 cells differentiate from precursor T helper cells in the presence of TGF-b and IL-6. Th17s co-express the chemokine receptors CCR4 and CCR6 which are necessary for the homing of Th17 cells into mucosal areas where they can participate in the elimination of bacterial and fungal infections [32] . Th17 cells secrete proinflammatory cytokine IL-17, which synergizes with IL-1 and TNF-a in activating the acute phase protein response. Th1 and Th17 cells are regulated by decidual NK cells that are producing galectin-1, a lectin with apoptotic activity on these immune cells. Increased expression of IL-17 was reported as a cause of spontaneous miscarriages and molar pregnancies [33] . In conclusion, an inverse relationship exists between the numbers of Th17 and Treg cells in the peripheral blood and decidua of women suffering from unexplained RPL. It is known that IL-6 is able to suppress the evolution of Treg cells and to direct their differentiation into the Th17 lineage. It has been shown that the serum level of IL-6 and soluble IL-6 receptor (sIL-6R) levels were increased in recurrent spontaneous cases [34] . Endometrial inflammation may start an autocrine loop for the formation of Th17 cells. In the presence of the raised levels of pro-pregnancy TGF-b, increased local levels of IL-6 may convert any naive T cells to Th17 cells instead of Tregs. It has been shown that Th17 cells were also increased in women with pre-eclampsia [35] .
Enhanced complement activation has also been an observed cause of RPL. Complement-inhibitory proteins such as MCP (membrane cofactor protein) and DAF (decay-accelerating factor) are involved in complement regulation throughout gestation [36] . Observed C3 and C4 levels were higher in women with a third miscarriage than in women with a history of two miscarriages who went on to have a successful pregnancy later [37] .
Foetal tolerance is also based on selective expression of HLA molecules on trophoblast cells. All trophoblast cells, villous as well as extravillous, lack the expression of HLA class II and of classical HLA class I molecules (HLA-A and -B) to prevent the interaction with maternal cytotoxic T cells. Only extravillous trophoblast cells express HLA class I molecules C, E, F and G. They interact with inhibitory receptors on NK cells, leading to their cytotoxic activity inhibition. HLA-G is recognised by receptors KIR2DL4, NKG2A (CD94), p49 and immunoglobulin-like transcript (ILT) receptor ILT2 (CD85j) [38] , and HLA-C interacts with KIR2DL1, 2, 3 and KIR2DS1,2 (the sole activating receptor) on decidual NK cells [39] . HLA-E presents signal peptides of HLA-A, B, C and G to inhibitory receptor NKG2 on NK cells [40] . Low expression of HLA-G in pregnant women has been associated with RPL and pre-eclampsia [41, 42] .
The HLA-G molecule, its structure and function
Human leukocyte antigen G (HLA-G) belongs to the nonclassical HLA-1b molecules and is encoded by a gene located on short arm of chromosome 6 (locus 6p23.1) close to the HLA-A region. The HLA-G gene is 4170 bp long and consists of 8 exons. Exon 1 encodes the peptide signal; exons 2, 3 and 4 the extracellular a1, a2 and a3 domains, respectively; exon 5 the cytoplasmic domain; and exon 6 the transmembrane domain of the heavy chain. Exon 7 and 8 are not translated because of the stop codon retained in exon 6 ( Figure 2 , [43, 44] ). The gene is translated into a 38 kDa protein that has the same structure as HLA class I antigens. It consists of one heavy chain that is associated with a b2-microglobulin, a light chain encoded by a gene on chromosome 15. Two of the three extracellular domains (a1 and a2) of heavy chain contribute to the peptide-binding groove. a and 1 light chain b2m) . Seven HLA-G isoforms can be generated by alternative splicing of the primary transcript. Four isoforms-HLA-G1, -G2, -G3 and -G4-are membrane-bound, while 3 isoforms-HLA-G5, -G6 and -G7-are soluble. 5'URR -upstream regulatory region, 3'UTR -untranslated region.
By an alternative splicing of the primary transcript, seven HLA-G isoforms can be generated. Four isoforms -HLA-G1, -G2, -G3 and -G4 -are membrane-bound, whereas three isoforms HLA-G5, -G6 and -G7 are soluble. Only the structure of the membrane-bound HLA-G1 molecule resembles the structure of other HLA-I molecules. Because of the stop codon in exon 6, the encoded cytoplasmatic domain is very short at only 6 amino acid residues [43] . To characterise other isoforms, the HLA-G2 isoform has no a2 domain, while HLA-G3 has no a2 and a3 domains and HLA-G4 lacks an a3 domain. The soluble HLA-G5 and -G6 molecules have the same extracellular domains as HLA-G1, but they lack the transmembrane domain due to a stop codon in intron 4. Lastly, the HLA-G7 isoform has only an a1 domain because of a stop codon in intron 2. All alternative transcripts lack exon 7 (Figure 2, [44] ). Soluble HLA-G molecules can be produced in two ways: either by alternative splicing of transcripts like sHLA-G5 or by shedding their proteolytic cleaved membranebound isoform like HLA-G1.
The expression of HLA-G is strictly restrictive, being mostly expressed in extravillous cytotrophoblast cells. HLA-G has also been detected in adult tissues, such the thymic medulla [45] , cornea, pancreas [46] or in human mononuclear phagocytes [47] . In addition, its expression can be induced under pathological conditions following transplantation [48] [49] [50] , tumors [51, 52] , viral infections [53] and autoimmune diseases [54, 55] . The immunosuppression seems to be beneficial in transplantation and autoimmune diseases, whereas it is detrimental in the case of tumors or viral infections. The major biological function of HLA-G is to maintain the acceptance of the foetus by the maternal immune system [7] . The immunosuppressive effect of HLA-G is based on: a) inhibition of cytotoxic activity of uterine and peripheral blood NK cells and CD8 + T cells; b) inhibition of the proliferation of alloreactive CD4 + T cells; c) inhibition of B cell activity; d) secretion of Th2 cytokines in PBMCs; and e) induction of regulatory T cells (Treg). While soluble HLA-G1 and HLA-G5 are known to have the above-described functions, the other HLA-G isoform functions have not been fully elucidated, except that of the membrane-bound HLA-G1, -G2, -G3 and -G4, which can inhibit the NK and T cell mediated cytolysis in vitro [56] . Immunosuppressive activity of HLA-G molecules is mediated through an interaction of its α1 domain with the inhibitory receptors of immune cells: ILT-2 expressed by NK, B, T and APC cells; ILT-4 on macrophages; and KIR2DL4 expressed by NK cells, respectively [38, 57] (Figure 3 ). Another immunosuppressive effect is based on destruction of cytotoxic CD8 + T cells and NK cells mediated by the binding of sHLAG molecule to CD8, leading to soluble FasL production by T lymphocytes and NK cells following their apoptosis by Fas/sFasL interaction [58] .
Besides the immune-tolerogenic effects, HLA-G is also capable of binding peptides of self-origin and viral origin; however, the absence of HLA-G restricted T cells shows that peptide presentation is not the major function of HLA-G [59, 60] .
Functional impact of HLA-G polymorphism
HLA-G polymorphisms were found in coding as well as in non-coding regions of the gene. Polymorphisms in coding regions can influence biological functions, namely peptide binding and/or isoform production, In the HLA-G*01:05N null allele, a deletion of cytosine in codon 130 (exon 3) causes a premature stop codon, leading to incomplete formation of the HLA-G1, -G4 and -G5 isoforms (which possess the a3 domain) and to expression of HLA-G2, -G3 and -G7 isoforms (which lack a3) [61, 62] . The other null allele -HLA-G*01:13N -contains a point mutation (C to T) at codon 54 in exon 2 (a1 domain) that causes a premature stop codon (TAG) leading to no HLA-G isoform production. The majority of polymorphisms found in the coding regions were seen in codons 31, 35, 57 and 69 of exon 2 and in codons 93, 107 and 110 of exon 3 [63] . Frequencies of the different HLA-G alleles vary between ethnic populations. The most frequent are alleles of the HLA-G*01:01 group, which comprise 50-60% in Caucasian and Japanese populations [64, 65] and about 80% in some African populations [66] . HLA-G has a higher number of SNPs in its noncoding region, including a promoter region at 5'UTR (untranslated region) and at 3'UTR. In the promoter region at 5'UTR, 29 SNPs were defined [67, 68] . Many of these polymorphisms are close to the known regulatory elements affecting the binding of the corresponding regulatory factors. In contrast to the HLA class I promoter, the HLA-G gene promoter possesses a few alternative regulatory elements. The promoter contains modified enhancerA and lacks ISRE (interferonstimulated response element) [69, 70] . The upstream region of the SXY module contains only conserved S and X1 sequences, but lacks the X2 and Y sequences that are responsible for the class II transactivator, namely CTIIA binding (Figure 4) . Only a few polymorphisms in the HLA-G promoter region have been associated with certain diseases until now. Nicolae et al., [71] found the association of the GG genotype (position -964 A/G) with asthmatic children from mothers affected by bronchial hyperresponsiveness, whereas the AA genotype was not associated with asthma in children of unaffected mothers. Another study found association between the -725G polymorphism and sporadic miscarriage [41] .
In the 3'UTR, a 14 bp deletion/insertion polymorphism in exon 8 was described, which can influence mRNA transcript size and stability ( Figure 5) . Rousseau et al. observed that the insertion of 14 bases (5´-ATTTGTTCATGCCT-3´) generates a 92 bp sequence deletion in the 3'UTR region, leading to the production of a more stable transcript. By contrast, if the 14 bp insertion is absent, the 92 bp sequence is retained and the transcript becomes unstable. It is due to the presence of the pentameric sequence AUUUG, involved in de-adenylation of HLA-G mRNA [72] . An association between the 14 bp insert and lower mRNA production has been observed -a study of 150 Chinese Han individuals with the homozygous genotype +14/+14 found significantly lower levels of sHLA-G molecules [73, 74] . It was found, in addition, that heterozygotes carrying the HLA-G*01:01:02 allele with a 14 bp insert had reduced levels of transcripts encoding membrane-bound isoforms (-G1, -G2 and -G3), whereas those carrying the HLA-G*01:01:03 Figure 4 . Structure of the promoter region of the HLA-G gene. The HLA-G promoter contains modified enhancerA (EnhA) and lacks ISRE (interferon-stimulated response element) which binds to NF-kB and IRF1. The upstream region of the SXY module contains only conserved S and X1 sequences, but lacks the X2 and Y sequences that are responsible for the class II transactivator CTIIA binding. Polymorphism at -964 A/G was associated with asthma [75] and at -725 C/G/T was associated with recurrent miscarriage [41] . LCRlocuscontrolregion,TSRE-tissuespecificregulatoryelement,IRF1-interferon-regulatoryfactor1,GAS-gammainterferonactivated site, SP1, p50 -transcription factors, RFX -protein complex, 5'URR -upstream regulatory region Figure 5 . Polymorphismatthe3'UTRoftheHLA-Ggene.The14bpinsertlocatedinthe3'UTRoftheHLA-GgenecaninfluencemRNAtranscript size and stability and was associated with recurrent pregnancy loss and pre-eclampsia [72, 73] . Other polymorphisms in the 3'UTR that caninfluencemRNAstabilityincludeSNPsatthe+3142position(C/G),associatedwithasthma [75] ,andatthe+3172position(G/A), associated with pre-eclampsia [42] . 3'UTR -untranslated region allele showed reduced levels of -G2 and -G4 isoforms [73] .
Other polymorphisms in the 3'UTR that can influence mRNA stability include SNPs at the +3142 position (C/G) and at the +3172 position (G/A), respectively. The +3142 polymorphism is a target for certain miRNAs that are responsible for degrading HLA-G mRNA; this polymorphism was associated with asthma [75] . The SNP at the +3172 position (G/A) is related to decreased mRNA stability and has been linked with pre-eclampsia [42] (Figure 5 ).
HLA-G and pregnancy disorders (recurrent pregnancy loss, preeclampsia)
Previous studies have confirmed that HLA-G plays an important role during pregnancy [7, 76] . HLA-G expression on the foeto-placental interface is important in the maternal acceptance of the semiallogenic foetus, preventing its rejection. The HLA-G expression on trophoblast cells begins in the first trimester during embryo implantation and proceeds until the end of pregnancy. Foetal tolerance is assured via the interaction of HLA-G on trophoblast cells and uterine NK cells expressing inhibitory receptor KIR2DL4. This interaction also regulates cytokine and chemokine secretion. Production of angiogenic factors that are involved in placental vascularisation and physiological foetal development is also induced [18] . Additionally, HLA-G expression is also important in the in vitro fertilisation (IVF) process. A positive correlation between the level of soluble HLA-G molecules in culture supernatants of embryos fertilized in vitro and successful implantation was found [77, 78] . The level of soluble HLA-G in the culture medium could potentially be evaluated as an additional marker for embryo selection in this process in order to facilitate successful pregnancies. The role of HLA-G in foetal tolerance was determined through observations of decreased HLA-G levels in the maternal serum correlating with pregnancy disorders such as recurrent spontaneous loss and pre-eclampsia [79] [80] [81] [82] [83] . Steinborn et al. [84] found that women with soluble HLA-G levels below 9.95 ng/ml have a relative risk of 7.0 for the development of placental abruption during pregnancy relative to healthy women. Some experiments have shown that the level of HLA-G may be linked with its gene polymorphism. Rebmann et al. [80] reported that the HLA-G alleles can be divided into high and low secretors; whereas the alleles G*01:01:3 (+14 bp) and G*01:05N (+14 bp) are low secretors, G*01:04:1 (-14 bp) is a high secretor, and G*01:01:1 and G*01:01:2 fall somewhere between them.
There is no consensus, which HLA-G alleles or HLA-G proteins predispose a mother to complications of pregnancy (summarised in Tables 1 and 2 ). Some studies did not find any association between HLA-G and recurrent spontaneous abortion [65, [85] [86] [87] [88] [89] or preeclampsia [90] [91] [92] . However, significant associations between HLA-G*01:05N, HLA-G*01:01:03 and HLA-G*01:04 alleles and recurrent spontaneous abortion have been documented in Caucasian populations [79, 93] , and in French and Chinese populations, the HLA-G*01:06 allele has been associated with preeclampsia [94, 95] . In relation to the 14 bp sequence insertion at the 3'UTR, many studies found significant elevated frequencies of +14/+14 bp alleles in women with RPL [96] [97] [98] and pre-eclampsia [99] compared to healthy controls. Xue et al. [100] reported that recurrent spontaneous abortion patients in Chinese populations have significantly more -14 bp/+14 bp heterozygotes in the 3'UT HLA-G gene region. In India, the alleles with the 14 bp insertion were also more frequent in patients with RPL compared to controls [101] . Vargas et al. [102] found significantly elevated frequencies of recurrent miscarriages (RM) in Brasilian women with haplotype HLA-G*01:01:08/+14bp and HLA-G*01:04:01/-14bp. By contrast, the haplotype group HLA-G*01:01x/+14bp exhibited a significant protective effect against RPL occurrence. Other polymorphisms in the 3'UTR at position +3127 (C/G) as well as at +3172 position (G/A) have been associated with pre-eclampsia [42, 103] . The last polymorphism was located before an AUUUA-pentamer sequence that is involved in mRNA stability. The latest study of Zhu et al. [83] described a significantly decreased HLA-G mRNA and protein level in pre-eclamptic placentas compared to physiological placentas.
Disease
Method HLA-Gfindings Reference recurrent spontaneous miscarriage PCR-RFLP no relationship between recurrent spontaneous miscarriage and any HLA-G allele in Finnish couples Karhukorpi et al., [85] habitual abortion PCR-SSCP nosignificancebetweenhabitualabortionandanyHLA-Gallele in Japanese couples Yamashita et al., [65] recurrent spontaneous abortion PCR-SSCP significantdifferenceinthedistributionoftheHLA-Galleles *01013 and *0105N between controls and the RSA group in a Caucasian population
Pfeiffer et al., [79] recurrent spontaneous abortion PCR-SSO significantdifferenceinthedistributionoftheHLA-Galleles *01:04 and *01:05N between controls and the RSA group in a Caucasian population
Aldrich et al., [93] recurrent spontaneous abortion sequencing significantdifferenceinthedistributionofthe+14bp/+14bp genotype between controls and the pre-eclamptic women in a Caucasian population
Hviid et al., [96] recurrent spontaneous abortion sequencing asignificantassociationofthe-725Galleleinthepromoter region with RSA in women of Caucasian origin Ober et al., [41] recurrent spontaneous abortion PCR nosignificantdifferenceinthedistributionofthe14-bpinsertion/ deletion genotype between controls and the RSA group in a Chinese population
Yan et al., [87] recurrent spontaneous abortion PCR significantlyincreasedfrequencyof-14bp/+14bp heterozygotes in RSA patients compared to normal fertile controls of Chinese ethnicity
Xue et al., [100] recurrent spontaneous abortion sequencing nosignificantdifferencebetweenrecurrentspontaneous abortion and any HLA-G allele in a Polish population Sipak-Szmigiel et al., [86] recurrent spontaneous abortion PCR significantelevatedfrequenciesofthegenotypeswith14bp polymorphism and the SNP3127 (C/G) in the 3' UTR in RSA women of Caucasian origin
Larsen et al., [103] recurrent spontaneous abortion sequencing significantdifferenceinthedistributionof12SNPsinthe promoter region of the HLA-G gene Berger et al., [97] recurrent spontaneous abortion sequencing nosignificantassociationbetweenrecurrentspontaneous abortion and any HLA-G allele in an Indian population Aruna et al., [88] recurrent spontaneous abortion PCR significantdifferenceinthedistributionofthe+14bp/+14bp genotype between Chinese women with four or more abortions and controls
Zhu et al., [98] recurrent spontaneous abortion PCR increasedfrequencyofthe+14bp/+14bpgenotypein RSA women compared to normal fertile controls in an Indian population Shankarkumar et al., [101] recurrent spontaneous abortion PCR significantelevatedfrequenciesofhaplotypesHLA-G*01:01:08/+14bpandHLA-G*01:04:01/-14bpinBrasilianRSA women
Vargas et al., [102] recurrent spontaneous abortion sequencing nosignificantdifferenceinthe14-bpinsertion/deletionallele frequencies among the RSA and control couples in a population in India
Aruna et al., [89] recurrent spontaneous abortion genotyping by SNapShot nosignificancebetweenrecurrentspontaneousabortionand any HLA-G allele association between a CC genotype at a promoter polymorphism, -725C/G/T, and lower concentrations of sHLA-G compared to the CG or CT genotypes in an Iraqi population Jassem et al., [104] In the promoter region at the 5'UTR, only one association -between the -725G variant and spontaneous miscarriages -was defined in Caucasian populations [41] . Recently, Jassem et al. [104] found a link between a CC genotype at a tri-allelic promoter polymorphism, -725C/G/T, and lower concentrations of sHLA-G compared to the CG or CT genotypes in the Iraqi population; however, this polymorphism did not differ significantly between cases and controls. Finally, Zhang et al. [105] found significant elevated frequencies of the +14 bp/+14 bp HLA-G genotype of the offspring in severe and early onset severe PE cases compared to controls in Chinese populations.
Following the described data, the level of HLA-G and its association with physiological pregnancy will depend on the HLA-G allele itself as well as on polymorphism in the 3' and 5' UTR. Further studies are needed to find associations between HLA-G polymorphisms, mRNA levels, protein levels and pregnancy disorders, including methods like mutagenesis and transfection.
Conclusions and future perspectives
Mild systemic immunosuppression and inflammation are features typical for physiological pregnancy. Until now the foetal-maternal interface was described like a graft vs. host interaction. To establish immune tolerance at the foetal-maternal interface, an exact temporal regulation between the immune and vascular systems is necessary. During pregnancy, the placenta produces and secretes various immunomodulatory factors to prevent rejection of the semiallogeneic foetus by the innate and adaptive immune mechanisms. The impairment of immune regulatory interactions between the mother and the developing foetus is one of the causes of pregnancy disorders such pregnancy loss and pre-eclampsia. As shown in recent studies, HLA-G is one of the molecules that plays a beneficial role in pregnancy. HLA-G molecules are expressed on trophoblast cells in the foetal placenta and induce foetal tolerance via the interaction of HLA-G with uterine NK cells and CD8 + T cells. Many studies have found associations between HLA-G function and pregnancy disorders. Future therapy of pregnancy disorders should increasingly consider factors and mechanisms that induce foetal tolerance, and HLA-G derivates or up regulators of HLA-G expression might be useful in this respect, though more studies with larger patient groups need to be done to codify these practices.
Disease
Method HLA-Gfindings Reference Pre-eclampsia PCR nosignificantdifferenceinthedistributionof14-bpinsertion/deletion polymorphism between controls and the pre-eclamptic women of a Caucasian population
Bermingham et al., [90] Pre-eclampsia sequencing significantdifferenceinthedistributionofthe+14bp/+14bpgenotype between controls and pre-eclamptic women of a Caucasian population Hylenius et al., [99] Pre-eclampsia PCR nosignificantdifferenceinthedistributionof14-bpinsertion/deletion polymorphism between controls and pre-eclamptic Brasilian women Vianna et al., [91] Pre-eclampsia PCR nosignificantdifferenceinthedistributionof14-bpinsertion/deletion polymorphism between controls and the pre-eclamptic women of a Caucasian population
Iversen et al., [92] Pre-eclampsia PCR-SSP significantdifferenceinthedistributionoftheHLA-Gallele*01:06between the pre-eclamptic women of a Caucasian population and controls Moreau et al., [94] Pre-eclampsia sequencing significantdifferenceinthedistributionoftheHLA-Gallele*01:06between controls and the pre-eclamptic women of a Chinese population Tan et al., [95] Pre-eclampsia PCR significantelevatedfrequenciesofthe+14bp/+14bpHLA-Ggenotypeof offspring in severe and early onset severe PE cases compared to controls in a Chinese population
Zhang et al., [105] 
